Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Summaries for Patients |3 June 2008

Screening for Type 2 Diabetes in Adults: U.S. Preventive Services Task Force Recommendations Free

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information

  • The summary below is from the full reports titled “Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement” and “ Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force.” They are in the 3 June issue of Annals of Internal Medicine (volume 148, pages 846-854 and pages 855-868). The first report was written by the U.S. Preventive Services Task Force; the second report was written by S.L. Norris, D. Kansagara, C. Bougatsos, and R. Fu.


Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • What is the U.S. Preventive Services Task Force?
    • What is the problem and what is known about it so far?
    • How did the USPSTF develop these recommendations?
    • What did the USPSTF find?
    • What does the USPSTF suggest that patients do?
    • What are the cautions related to these recommendations?
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

What is the U.S. Preventive Services Task Force?

The U.S. Preventive Services Task Force (USPSTF) is a group of health experts that reviews published research and makes recommendations about preventive health care.

What is the problem and what is known about it so far?

Diabetes mellitus is a common disease that interferes with the body's ability to store energy from food. The pancreas makes a substance called insulin, which helps to store energy from food. Type 1 diabetes (juvenile diabetes) occurs when the pancreas stops making insulin. In type 2 diabetes (adult-onset diabetes), the body makes plenty of insulin but is unable to use it normally. In both cases, the result is high blood sugar levels. Over time, high blood sugar levels can lead to blindness, kidney failure, nerve damage, and heart disease. Fortunately, good care with diet, exercise, and medications can prevent the development of complications. Good care includes treatment to keep blood sugar levels normal. People with diabetes have more heart attacks and strokes than people without diabetes. Controlling blood pressure and cholesterol helps to prevent these complications. For people with diabetes who also have high blood pressure and cholesterol problems, good care also includes treatment of these conditions. Type 1 diabetes usually does not go long before being diagnosed. However, many people with type 2 diabetes have diabetes for years before symptoms begin.
Testing people who have no symptoms to try to detect disease early is called screening. Screening for diabetes would be helpful only if people who begin treatment before symptoms develop do better than people who start treatment after symptoms develop. Screening for diabetes involves blood tests to look for high blood sugar levels.

How did the USPSTF develop these recommendations?

The USPSTF reviewed published research to measure the benefits and harms of testing for diabetes in people with no symptoms.

What did the USPSTF find?

The USPSTF did not find studies that prove that treating people with normal blood pressure and diabetes to lower blood sugar before they have symptoms leads to fewer diabetes complications (such as heart attacks, strokes, or kidney problems) than if treatment begins when symptoms develop. No studies have looked at the long-term harms of diabetes screening. Short-term harms include worry caused by labeling people as having diabetes and giving them diabetes treatments. However, the USPSTF did find studies that show that people with high blood pressure (>135/80 mm Hg) and diabetes have fewer heart attacks and strokes if blood pressure is lowered below this level.

What does the USPSTF suggest that patients do?

Patients with normal blood pressure (≤135/80 mm Hg) should know that it is unclear whether screening for diabetes would help them. These patients should discuss diabetes screening with their doctors.
Patients with high blood pressure (>135/80 mm Hg) should be screened for diabetes.

What are the cautions related to these recommendations?

These recommendations do not apply to people who have symptoms that might be due to diabetes. Patients with symptoms should be tested for diabetes. The recommendations may change as new studies become available.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Screening for Type 2 Diabetes in Adults: U.S. Preventive Services Task Force Recommendations. Ann Intern Med. 2008;148:I–30. doi: https://doi.org/10.7326/0003-4819-148-11-200806030-00001

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2020

×
Permissions

Published: Ann Intern Med. 2008;148(11):I-30.

DOI: 10.7326/0003-4819-148-11-200806030-00001

©
2008 American College of Physicians
0 Citations
Advertisement

See Also
Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement
Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force
View MoreView Less

Related Articles
Screening Adults for Type 2 Diabetes Mellitus: Recommendations from the U.S. Preventive Services Task Force
Annals of Internal Medicine; 138 (3): I-52
What the U.S. Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation
Annals of Internal Medicine; 157 (2): 137-138
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine; 157 (2): I-44
Behavioral Counseling to Prevent Skin Cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine; 157 (1): 59-65
View MoreView Less

Journal Club
Protocol-based nurse management of type 2 diabetes did not differ from usual GP care for HbA1c levels
Annals of Internal Medicine; 155 (6): JC3-7
View MoreView Less

Related Point of Care
Type 2 Diabetes
Annals of Internal Medicine; 171 (9): ITC65-ITC80
Type 2 Diabetes
Annals of Internal Medicine; 162 (5): ITC1
Type 2 Diabetes
Annals of Internal Medicine; 152 (5): ITC3-1
Type 2 Diabetes
Annals of Internal Medicine; 146 (1): ITC1-1
View MoreView Less

Related Topics
Cardiology
Coronary Risk Factors
Diabetes
Endocrine and Metabolism

Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.

PubMed Articles
A Minimal Model Approach for the Description of Postprandial Glucose Responses from Glucose Sensor Data in Diabetes Mellitus.
Conf Proc IEEE Eng Med Biol Soc 2019;2019():265-268.
Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors.
Bioorg Med Chem Lett 2020;30(4):126930.
View More

Results provided by: PubMed

Advertisement
CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2020 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×